Regulation of responses to therapeutic antibodies by macrophages derived from chronic lymphocytic leukaemia patients

Abstract

Breakpoint cluster region protein BTK Bruton's tyrosine kinase CAV-1 Caveolin-1 CAV-2 Caveolin-2 CCL2 CC motif chemokine ligand 2 CCL3 CC motif chemokine ligand 3 CCL4 CC motif chemokine ligand 4 CCR1 CC chemokine receptor type 1 CCR2 CC chemokine receptor type 2 CCR4 CC chemokine receptor type 4 CCR5 CC chemokine receptor type 5 CD14 Cluster of differentiation 14 CD163 Cluster of differentiation 163 CD20 B-lymphocyte antigen CD20 CD4 Cluster of differentiation 4 CD47 Leukocyte surface antigen CD47 CD52 CAMPATH-1 antigen CD62L L-selectin CD68 Cluster of differentiation 68 CDK1 Cyclin-dependent kinase 1 CDK9 Cyclin-dependent kinase 9 CLL Chronic lymphocytic leukaemia COVID19 Coronavirus disease 2019 CSF1R Colony stimulating factor 1 receptor CSK C-terminal Src kinase CXCL12 C-X-C motif chemokine 12 CXCL13 C-X-C motif chemokine ligand 13 CXCL19 Chemokine (C-X-C motif) ligand 19 CXCL20 Chemokine (C-X-C motif) ligand 20 DC Dendritic cell Goat anti-mouse Alexa Fluor 488